Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes

By Rodrguez L.E.   Urquiza M.   Ocampo M.   Curtidor H.   Suarez J.   Garca J.   Vera R.   Puentes A.   Lopez R.   Pinto M.   Rivera Z.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1331-1339

Elsevier

Access to resources Recommend Favorite

Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1 19 expressed in distinct bacterial vectors

By Cunha M.G.   Rodrigues M.M.   Soares I.S.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 385-396

Elsevier

Access to resources Recommend Favorite

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1 19 ) and T helper epitopes of tetanus toxoid

By Keitel W.A.   Kester K.E.   Atmar R.L.   White A.C.   Bond N.H.   Holland C.A.   Krzych U.   Palmer D.R.   Egan A.   Diggs C.   Ballou W.R.   Hall B.F.   Kaslow D.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 531-539

Elsevier

Access to resources Recommend Favorite

Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax

By de Oliveira C.I.   Wunderlich G.   Levitus G.   Soares I.S.   Rodrigues M.M.   Tsuji M.   del Portillo H.A.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2959-2968

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein

By Urquiza M.   Suarez J.E.   Cardenas C.   Lopez R.   Puentes A.   Chavez F.   Calvo J.C.   Patarroyo M.E.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 508-513

Elsevier

Access to resources Recommend Favorite